Replies to post #980 on Enanta Pharmaceuticals Inc (ENTA)

[pollyvonwog]

FWIW since some RXs are being blocked the avg NRx per week in Q1 from symphony was 288. The avg in April (2 weeks only) has been 488. Just going by that I think it's going to be pretty easy for them to at least double their US v-pak sales in Q2.

[DewDiligence]

V-Pak 2Q15 sales were $385M, +67% vs 1Q15 (but below analysts’ consensus):

http://finance.yahoo.com/news/abbvie-reports-second-quarter-2015-115300591.html